Acetazolamide Tablet
Product Images NDC 42291-090

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Acetazolamide (NDC 42291-090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Screen Shot 2017 05 18 At 1.42.38 Pm)

The text appears to be a mixture of scanned text, containing alphanumeric characters, special characters, and symbols. It is unclear what the information refers to, but mentions different abbreviations such as DI, BLIBENL DSEId, and NDC 42291-089-01. The mention of "AcetaZOLAMIDE Tablets, USP" suggests the scanned text could be referring to medication. However, due to the incomprehensible nature of the text, it is not possible to provide a more precise description of this document.*

FDA Label Image

3 (Screen Shot 2017 05 18 At 1.42.50 Pm)

FDA Label Image

Structure (Da71ea5e 62ae 47d0 8fa5 7fb9d95a03ab 01)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.